Friedemann Geiger

University Hospital Schleswig-Holstein

Papers

1

Total Citations

7

H-Index

1

About

Friedemann Geiger is a leading voice in the surgical treatment of gynecologic oncology, with a focused expertise in the management of cervical cancer. His work critically examines the evolving debate between open radical hysterectomy (ORH) and minimally invasive surgery (MIS), a controversy ignited by landmark trials like LACC. In his most cited work (2021), Geiger systematically assessed disease-free survival, overall survival, and morbidity rates, providing a rigorous analysis of the trade-offs between these approaches. By synthesizing clinical data and engaging expert discussion on the implications of the LACC trial, he has helped clarify the risks and benefits for early-stage cervical cancer patients. His contributions are pivotal for surgeons navigating this paradigm shift, ensuring that patient outcomes remain the central focus. With over 7 citations on this key paper alone, Geiger’s research is shaping clinical guidelines and sparking necessary debate. His work stands as a critical resource for students and clinicians seeking evidence-based clarity in a rapidly changing surgical landscape.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Challenges and Controversies in the Surgical Treatment of Cervical Cancer: Open Radical Hysterectomy versus Minimally Invasive Radical Hysterectomy
7 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: University Hospital Schleswig-Holstein

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago